News

Preeclampsia is a syndrome that occurs during pregnancy and is marked by a sudden increase in the blood pressure of a pregnant woman after the 20th week of pregnancy. It can affect the mother's kidneys, liver, and brain. The condition can be fatal for the mother and/or the baby and can lead to long-term health problems.

​Preterm births have fallen for the fifth straight year in a row, reported the National Center for Health Statistics of the Center for Disease Control and Prevention, in one of its recent National Vital Statistics Reports. This welcome decline was seen for all groups, and for each stage of pregnancy.

​The September 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online. The podcast features discussions of research on how a gene found in a rare cancer increases red blood cell production, the involvement of “dark matter” DNA in the body’s response to day and night cycles, and on cesarean delivery versus labor for preterm infants.

​Most children exposed to high levels of alcohol in the womb do not develop the distinct facial features seen in fetal alcohol syndrome, but instead show signs of abnormal intellectual or behavioral development, according to a study by researchers at the National Institutes of Health and researchers in Chile.

The July 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online.  This month’s podcast features research sponsored by the NICHD’s Pediatric, Adolescent and Maternal AIDS Branch.

The infant mortality rate, the preterm birth rate, and the adolescent birth rate all continued to decline, average mathematics scores increased for 4th and 8th grade students, the violent crime victimization rate among youth fell, as did the percentage of young children living in a home where someone smoked, according to the federal government’s annual statistical report on the well-being of the nation’s children and youth.

Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.

Secretary Sebelius addressed the researchers at the Network's Annual Steering Committee meeting this month. The Network, established by the NICHD and the Bill and Melinda Gates Foundation, seeks to prevent maternal and infant deaths and illnesses worldwide. Scientists from developing countries, together with those in the United States, lead teams that identify the health needs of an area and address those needs through randomized clinical trials to test treatments and interventions.

The Society for Clinical Trials (SCT) has selected the NICHD Management of Myelomeningocele Study (MOMS) as its 'Trial of the Year.'

Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.

Item of Interest: Video Presentation: Role of Research in Understanding, Preventing, and Treating Birth Defects

The newly released 2011 DIR Annual Report reviews the latest basic, clinical, and translational research being pursued by the staff scientists within DIR at the NICHD. Contributing to this effort are 79 tenured and tenure-track investigators and approximately 1,200 administrative and research staff. In 2011, DIR project areas ranged from vaccine development to genomics, from reproduction to regenerative medicine, and from the neurosciences and early human development to biophysics and imaging.

Women who consumed a diet high in animal fat and cholesterol before pregnancy were at higher risk for gestational diabetes than women whose diets were lower in animal fat and cholesterol, according to researchers at the National Institutes of Health and Harvard University.

An analysis of five previous studies has uncovered additional evidence of the effectiveness of progesterone, a naturally occurring hormone, in reducing the rate of preterm birth among a high-risk category of women.

An NIH scientist whose landmark collaborations led to a major advance in understanding a potentially fatal disorder of pregnancy has passed away.

A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women.

NICHD Director Alan E. Guttmacher, M.D., initiated the NICHD Director’s Lecture Series as a way to showcase cutting-edge science relevant to the Institute’s mission. The forum also enables staff and other attendees to interact with other nationally recognized scientists.

The Division’s research programs address topics ranging from molecular and cellular biology, genetics, and endocrine and genetic disorders, to physical biology, neurosciences, immunology, reproduction, and behavioral research. Its projects are organized around the theme of the orchestration of life by molecular messengers.

Taking vitamin C and E supplements starting in early pregnancy does not reduce the risk for the hypertensive disorders and their complications that occur during pregnancy, according to a study by a National Institutes of Health research network.

On January 15, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD launched the Promoting Maternal-Infant Survival Everywhere—or PROMISE—study.